Using a genomic approach and oncogenic HRAS-driven cancer cells as models, we identified the endolysosomal Ca2+ permeable channel, TRPML1, as a potential target in cells harboring oncogenic HRAS [29]. This evidence concerns the gene MCOLN1 and cancer.